Knoles

1 2 3 UNITED STATES DISTRICT COURT 4 NORTHERN DISTRICT OF CALIFORNIA 5 SAN JOSE DIVISION 6 7 MARLESSA KNOLES, Case No. 17-cv-06580-BLF

8 Plaintiff,

ORDER DISMISSING SECOND

9 v. AMENDED COMPLAINT AS TO ALL

REMAINING DEFENDANTS; AND

10 TEVA PHARMACEUTICALS USA, INC.; DISMISSING ACTION WITHOUT

TEVA BRANDED PHARMACEUTICALS PREJUDICE

11 PRODUCTS R&D, INC.; FEI WOMEN’S

HEALTH LLC; ORTHO-MCNEIL

12 PHARMACEUTICAL, LLC; and

DURAMED PHARMACEUTICALS,

13 Defendants. 14 15 16 On October 17, 2019, the Court granted the Teva Defendants’ motion to dismiss the 17 second amended complaint (“SAC”) for lack of personal jurisdiction, without leave to amend. See 18 Order, ECF 81. 19 The Court also ordered Plaintiff to show cause, in writing and on or before October 31, 20 2019, why the second amended complaint should not be dismissed with respect to the three 21 remaining defendants, FEI Women’s Health LLC, Ortho-McNeil Pharmaceutical, LLC, and 22 Duramed Pharmaceuticals. See Order, ECF 81. The Court stated its view that…